Narrow search
Showing 1 - 10 of 291,770
Cover Image
Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market
Cavaliere, Alberto; Moayedizadeh, Ashin - 2022
Persistent link: https://www.econbiz.de/10014232582
Cover Image
Collusion in the US generic drug industry
Clark, Robert; Fabiilli, Christopher Anthony; Lasio, Laura - 2021
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Why brand drugs priced higher than generic equivalents
Iacocca, Kathleen; Sawhill, James; Zhao, Yao - In: International journal of pharmaceutical and healthcare … 9 (2015) 1, pp. 3-19
Persistent link: https://www.econbiz.de/10011302283
Cover Image
U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016
Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26
Persistent link: https://www.econbiz.de/10012182277
Cover Image
Essays on the economics of pharmaceuticals
Virabhak, Suchin - 2005
Persistent link: https://www.econbiz.de/10003550944
Cover Image
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Conti, Rena M. - 2019
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales … cohorts; (iii) the extent of competition is greatest for the oldest molform cohorts and is smallest for the youngest molform … cohorts. With a median of one competitor, the extent of competition in the youngest molform cohort is very limited; and (iv …
Persistent link: https://www.econbiz.de/10012480138
Cover Image
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Conti, Rena - 2019
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales … cohorts; (iii) the extent of competition is greatest for the oldest molform cohorts and is smallest for the youngest molform … cohorts. With a median of one competitor, the extent of competition in the youngest molform cohort is very limited; and (iv …
Persistent link: https://www.econbiz.de/10012862864
Cover Image
The determinants of pricing in pharmaceuticals : are US prices really so high?
Cabrales, Antonio; Jiménez-Martín, Sergie - 2008
Persistent link: https://www.econbiz.de/10010442786
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133